Display Settings:

Format

Send to:

Choose Destination
    Arch Ophthalmol. 2007 Oct;125(10):1396-401.

    C-reactive protein level and risk of aging macula disorder: The Rotterdam Study.

    Source

    Department of Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands.

    Abstract

    OBJECTIVE:

    To examine whether C-reactive protein (CRP) level is a risk factor for aging macula disorder (AMD) in a general population.

    METHODS:

    We examined serum high-sensitivity CRP (HsCRP) levels in 4914 participants of the population-based Rotterdam Study at risk for AMD. After a mean follow-up of 7.7 years, 561 cases of early and 97 cases of late incident AMD (iAMD) were identified. We used Cox proportional hazards regression models to estimate hazard ratios and corresponding 95% confidence intervals (CIs).

    RESULTS:

    After adjustment for age and sex, hazard ratios were 1.11 (95% CI, 1.02-1.21) per standard deviation increase in HsCRP level for early iAMD and 1.28 (95% CI, 1.02-1.60) for late iAMD. Hazard ratios for early iAMD increased per quartile increase in HsCRP level as follows: second quartile, 1.19 (95% CI, 0.94-1.52); third quartile, 1.29 (95% CI, 1.01-1.64); and fourth quartile, 1.33 (95% CI, 1.05-1.70). The risk of late iAMD was higher in all upper quartiles of HsCRP.

    CONCLUSION:

    Elevated baseline levels of HsCRP were associated with the development of early and late AMD in this large population-based cohort.

    PMID:
    17923549
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for Silverchair Information Systems

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk